Michel Nussenzweig
Investigator, Howard Hughes Medical Institute · University of Pennsylvania Health System
Credentials: · · ·
History
Infectious Disease
Internal Medicine
Research
Review · Annual Review of Immunology · 2003 · Last of 3 authors · 2,362 citations
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Science · 2020 · 2,224 citations
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Science · 2020 · 1,856 citations
- MC
101 papers
- DS
25 papers · 3 as a resident
21 papers
18 papers · 2 as a resident
- YC
15 papers · 3 as a fellow
- BW
14 papers
- JM
13 papers
- IK
11 papers · 2 as a resident
Grants
- 2008–2030
Immunity and Infectious Disease
National Institute of Allergy and Infectious Diseases · T32
Contact PI · $3.3M · Rockefeller University
- 2025–2030
INSPIRE: Innovative Strategies for Personalized Immunotherapies and Reservoir Eradication
National Institute of Allergy and Infectious Diseases · UM1
PI · $5.9M · Weill Medical Coll of Cornell Univ
- 2013–2028
Developing Immunogens to Elicit Broadly Neutralizing Anti-HIV-1 Antibodies
National Institute of Allergy and Infectious Diseases · P01
PI · $39.1M · California Institute of Technology
- 2022–2025
Broad Neutralization of Pandemic Threat Coronaviruses
National Institute of Allergy and Infectious Diseases · P01
PI · $10.7M · Rockefeller University